BBI Cambridge Joins International Life Sciences Leaders at the LSBC Central European Life Science Investment Conference 2026
Kraków, Poland, October 2026 - BBI Cambridge participated as a Platinum Partner in the 13th LSBC Central European Life Science Investment Conference, held in Kraków, Poland, from 21 to 23 October 2026. The event brought together investors, entrepreneurs, senior executives, researchers and industry representatives to explore the opportunities shaping the future of the life sciences sector.
Under the theme “Investing in Intelligence, Engineering Life: AI and the Life Science Industry”, the conference examined the growing influence of artificial intelligence across biotechnology, healthcare, drug discovery and investment. Discussions focused on how emerging technologies are transforming research and development, changing investment strategies, creating new commercial opportunities and influencing the development of life sciences companies.
The invitation-only conference brought together approximately 120 senior participants, providing a focused environment for high-level discussions and the development of international relationships across the life sciences investment ecosystem.
International perspectives on investment, innovation and AI
The programme featured contributions from an international group of investors, industry executives, entrepreneurs and academic experts, representing organisations including the European Investment Fund, BrightCap Ventures, Lunar Ventures, VP Venture Partners, Resonance Health Europe, Sterne Kessler, the University of Sussex, Ardigen, QSAR Lab and Arthur D. Little.
Sessions explored the impact of AI on investment strategy and exit dynamics, the relationship between artificial intelligence and intellectual property, the opportunities for Central and Eastern Europe to strengthen its position in AI-driven life sciences, and the application of AI across drug discovery, development and food technology.
The discussions reflected the importance of connecting scientific innovation with investment, commercial strategy and the expertise required to bring new technologies to market.
BBI Cambridge supports the next generation of life sciences ventures
As a Platinum Partner, BBI Cambridge contributed to the conference programme and supported the Company Pitch Competition, which brought together 17 innovative companies presenting their technologies and business propositions to an international panel of investors and industry experts.
The competition was introduced by Mark Treherne, Curriculum Co-ordinator at BBI Cambridge, and included a scholarship opportunity for the BBI Life Science MBA. Mark also joined the judging panel, contributing his experience in life sciences investment, company development and the commercialisation of scientific innovation.
The competition recognised QurieGen, represented by Kinga Matuła, as the first-place winner, with Onena Medicines, represented by Neethan Lobo, receiving second place.
The initiative reflected BBI Cambridge’s commitment to supporting entrepreneurship and strengthening the capabilities of emerging life sciences companies as they move from scientific innovation towards investment readiness and commercial development.
Strengthening international life sciences connections
The conference provided an opportunity to reinforce relationships between the UK, Poland and the wider European life sciences ecosystem. It also highlighted the importance of collaboration between investors, universities, technology transfer organisations, entrepreneurs and established industry participants in supporting the development of innovative companies.
BBI Cambridge was pleased to participate alongside fellow Platinum Partners Resonance Health Europe and Three Islands Consulting, as well as the conference's wider network of sponsors and supporting organisations.
Through its international activities, BBI Cambridge continues to connect scientific innovation, entrepreneurship, investment and executive development, contributing to the growth of life sciences ecosystems and the development of the next generation of industry leaders.
About BBI Cambridge
BBI Cambridge is an international academic institution specialising in the management of life sciences. It develops executive talent worldwide and works at the intersection of scientific innovation, entrepreneurship, investment and business development.
With its headquarters in Cambridge, UK, and an international presence connecting Europe, the Americas and the Middle East, BBI Cambridge supports professionals and organisations working to translate scientific knowledge and technological innovation into sustainable business and societal impact.
